ANTI-IL1RAP ANTIBODY COMPOSITIONS

The present invention relates to antibody compositions directed to Interleukin 1 Receptor Accessory Protein (IL1RAP) and their use in the treatment and diagnosis of diseases associated with IL1RAP, such as inflammatory, autoimmune, autoinflammatory and neoplastic disorders.

Saved in:
Bibliographic Details
Main Authors FORSBERG, Göran, LIBERG, David, VON WACHENFELDT, Karin, SJÖSTRÖM, Kjell
Format Patent
LanguageEnglish
French
German
Published 23.06.2021
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention relates to antibody compositions directed to Interleukin 1 Receptor Accessory Protein (IL1RAP) and their use in the treatment and diagnosis of diseases associated with IL1RAP, such as inflammatory, autoimmune, autoinflammatory and neoplastic disorders.
AbstractList The present invention relates to antibody compositions directed to Interleukin 1 Receptor Accessory Protein (IL1RAP) and their use in the treatment and diagnosis of diseases associated with IL1RAP, such as inflammatory, autoimmune, autoinflammatory and neoplastic disorders.
Author FORSBERG, Göran
LIBERG, David
SJÖSTRÖM, Kjell
VON WACHENFELDT, Karin
Author_xml – fullname: FORSBERG, Göran
– fullname: LIBERG, David
– fullname: VON WACHENFELDT, Karin
– fullname: SJÖSTRÖM, Kjell
BookMark eNrjYmDJy89L5WRQdPQL8dT19DEMcgxQALGd_F0iFZz9fQP8gz1DPP39gnkYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSbxrgLGFsbmRhbGjoTERSgC6ACO1
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate COMPOSITIONS D'ANTICORPS ANTI-IL1RAP
ANTI-IL1RAP-ANTIKÖRPERZUSAMMENSETZUNGEN
ExternalDocumentID EP3837283A1
GroupedDBID EVB
ID FETCH-epo_espacenet_EP3837283A13
IEDL.DBID EVB
IngestDate Fri Jul 19 13:01:03 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP3837283A13
Notes Application Number: EP20190755895
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210623&DB=EPODOC&CC=EP&NR=3837283A1
ParticipantIDs epo_espacenet_EP3837283A1
PublicationCentury 2000
PublicationDate 20210623
PublicationDateYYYYMMDD 2021-06-23
PublicationDate_xml – month: 06
  year: 2021
  text: 20210623
  day: 23
PublicationDecade 2020
PublicationYear 2021
RelatedCompanies Cantargia AB
RelatedCompanies_xml – name: Cantargia AB
Score 3.3360224
Snippet The present invention relates to antibody compositions directed to Interleukin 1 Receptor Accessory Protein (IL1RAP) and their use in the treatment and...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title ANTI-IL1RAP ANTIBODY COMPOSITIONS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210623&DB=EPODOC&locale=&CC=EP&NR=3837283A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-KcSgXpW9H0a9lDkTZtWcU2ZVaZT2PtMtjLHK7Df99L6KYv-nYkkE9-ufsluTuAuwez6s8onaPlZs0NeyqIQQcObohVUmITWlKVtC_N3OGr_TR2xi1YbH1hVJzQLxUcERFVId5rdV6vfi6xQvW3cn1fLrDo4zEuvFBv2DHyF1Tnehh4Uc5DznTGUNKzkSeJGGpSH4nSHlrRfQmG6C2QTimr3xolPob9HBtb1ifQEssOHLJt4rUOHKTNezeKDfTWp3DrZ0ViJM9k5OealAMevmuMpzl_SZQv8BlocVSwoYF9TXbzmkT5blTWObSR7osL0NzKtBBVM-I6wqbmoDTRYqjQEkJm5E5t0oXun81c_lPXgyO5QPKbk2ldQbv-3IhrVKh1eaOW4htePXSr
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFetNq2J9RpDcgm5e3R6CJLsJieZFjVJPoUlT6KUWG_HvO1nS6kVvwy7sY5ZvZ77dnVmA23u1HM4onaPnps0VfVoRhY4MXBCtoEQntKDi074oNv0X_XFiTDqw2MTCiDyhXyI5IiKqRLzXYr9e_RxicfG2cn1XLLDo_cHLLC637Bj5C5pzmTuWmyY8YTJjKMnx2GqIGFpSG4nSDnrYwwYM7qvTBKWsflsU7wB2U2xsWR9Cp1r2occ2H6_1YS9q77tRbKG3PoIbO84CJQjJ2E6lRnYS_iaxJEqT50DEAh-D5LkZ8xXsK9_OK3fT7ai0E-gi3a9OQTJLVUNUzYhpVDpVR4WKHkOJnhAyI3OqkwEM_mzm7J-6a-j5WRTmYRA_ncN-oyxFJIi8gG798VldonGtiyuhlm8B3nei
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=ANTI-IL1RAP+ANTIBODY+COMPOSITIONS&rft.inventor=FORSBERG%2C+G%C3%B6ran&rft.inventor=LIBERG%2C+David&rft.inventor=VON+WACHENFELDT%2C+Karin&rft.inventor=SJ%C3%96STR%C3%96M%2C+Kjell&rft.date=2021-06-23&rft.externalDBID=A1&rft.externalDocID=EP3837283A1